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Background
In 2021, the American Cancer Society estimated that 
approximately 21,410 women will receive a new 
diagnosis of ovarian cancer and about 13,770 women 
will die from ovarian cancer in the United States. This 
type of cancer is treated with cyto-reductive surgery, 
radiotherapy and hormone therapy, but unfortunately, 
these treatments are often insufficient, and patients 
frequently relapse and succumb to the disease (Yajid et 
al., 2018).
The Annona muricata plant contains specific 
compounds denominated acetogenins (ACGs), which 
are characterized by C35 or C37 unbranched fatty acid 
with a γ-lactone at the end of the skeleton (Kim et al., 
1998). A single report demonstrated ACGs might 
increase or decrease the expression of Notch receptors 
(Li et al., 2017) in cancer cells. The Notch signaling 
pathway controls a variety of cellular processes, such 
as cell proliferation, differentiation, apoptosis, and 
survival. Additionally, abnormities of Notch signaling 
is associated with oncogenesis, which usually 
manifests as abnormality ligands, receptors, and 
downstream proteins (Hu et al., 2012). 
In this study, we isolated and characterized ACGs, 
modulators of the Notch pathway, and demonstrate 
their antitumoral activity in ovarian cancer.
Methods
Cells were plated onto 24-well plates (300 cells/well). 
After, they were treated with ACGs (0, 15, and 25 
nM). They were incubated in 5% CO2 and 95% air at 
37 ºC for 10 days to form colonies. At the end of the 
incubation, the colonies were stained with crystal 
violet and counted.
To discover the effects of ACGs on cell proliferation, 
we performed an Alamar-Blue assay with OCVAR5 
and OVCAR8 cells at 24, 48, and 72 hours.
Wound-healing assay was performed by first seeding 
the cells onto a 6-well plate, scraping the surface, and 
monitoring for 24 hours as the area closed.
Conclusions
In this study, we demonstrated that using ACGs to 
target Notch signaling has both antitumoral and anti-
metastatic effect in high grade ovarian cancer. The 
many biological and clinical aspects of ovarian 
tumorigenesis indicate that an aberrant activation of 
Notch signaling pathway is involved in tumor 
initiation, progression, metastasis, resistance to 
chemotherapy, and angiogenesis. Based on previous 
reports, we hypothesized ACGs would down-regulate 
the Notch signaling-pathway, and thus inhibit these 
behaviors.
In the current study, we demonstrated for the first time 
that treatment with ACGs decreased Notch1 
expression in a dose-dependent manner in OVCAR5, 
and higher concentrations of ACGs similarly 
decreased the expression of the same receptors in 
OVCAR8. It was additionally found that treatment 
with ACGs decreased proliferation in these same cell 
lines. 
Cancer metastasis is dependent on the cells’ migratory 
ability and proliferative capabilities. And it was found 
by wound-healing assay demonstrated that ACGs 
inhibit the migratory activity of ovarian cancer cells in 
vitro. Together with the noted anti-proliferative effects 
of ACGs, this suggests they may be effective at 
preventing metastasis. These effects may be explained 
by the reductions observed in p-Erk1/2 and Notch1 
following treatment with ACGs, both involved in 
pathways that modulate cancer cell migration and 
proliferation.
The results presented here indicate that ACGs isolated 
from Annona muricata act as anti-metastatic agents 
that can attenuate the proliferation of HGSOC, and 
they may provide a novel therapeutic approach against 
HGSOC. With few treatment options available, ACGs 
have the potential to greatly improve patient outcomes, 
although further studies will be necessary to confirm 
their effects in vivo.
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Results
Figure 3. It was observed that ACGs significantly decreased colony formation in both OVCAR5 (p=0.004) 
and OVCAR8 (p=0.0042) cells compared to the negative controls.
Figure 2. ACGs were found to inhibit proliferation of OVCAR5 (top) and OVCAR8 (bottom) cells in vitro. 
General Aims
Our primary goals were to characterize the Notch 
signaling-pathway and explain the anti-tumoral 
activity of ACGs in ovarian cancer. We 
hypothesized there would be a  down-regulation of 
the Notch receptors as well as reduced metastatic 
capability following treatment with ACGs.
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Figure 5. Wound-healing assay showed a reduction of migratory capacity following treatment with ACGs.







Figure 4. Western blot analysis showed a reduction of Notch1 and p-Erk1/2, in line with the decreased 
colony formation observed.
Translational significance
ACGs isolated from plants of the genus Annonaceae
have been shown to have antitumor effects in cancer 
cell lines. However, the molecular signaling pathways 
underlying this effect are not fully understood. Our 
findings suggest a regulatory effect of ACGs derived 
from soursop fruit pulp on Notch signaling pathway in 
HGSOC, suggesting they may pose a potential 
therapeutic approach against ovarian cancer.
